Coronary bioadaptors will replace drug-eluting stents: pros and cons.

Erlinge D, Mancini G, Paradies V

Open source

DOI
10.4244/eij-e-26-00014
Published
2026 Aug 17
Container
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.4244/eij-e-26-00014,
  title = {Coronary bioadaptors will replace drug-eluting stents: pros and cons.},
  author = {Erlinge D and Mancini G and Paradies V},
  year = {2026},
  journal = {EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology},
  doi = {10.4244/eij-e-26-00014},
  url = {https://doi.org/10.4244/eij-e-26-00014}
}

RIS

TY  - JOUR
TI  - Coronary bioadaptors will replace drug-eluting stents: pros and cons.
AU  - Erlinge D
AU  - Mancini G
AU  - Paradies V
PY  - 2026
JO  - EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
DO  - 10.4244/eij-e-26-00014
UR  - https://doi.org/10.4244/eij-e-26-00014
ER  - 

APA

D, E., G, M., & V, P. (2026). Coronary bioadaptors will replace drug-eluting stents: pros and cons.. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. https://doi.org/10.4244/eij-e-26-00014

Source records